Have to add more here mate, for 'doubles' the efficacy when comparing with Keytruda mono, that is the NSCLC case. In head and neck cohort, this type is so much harder and EFTI combo is trippling compare to Keytruda mono, plus the duration of responding (convert to the quality of response) is even greater extent.
Overnight Market report, page-1484
-
- There are more pages in this discussion • 1,359 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.5¢ |
Change
-0.005(1.25%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 40.0¢ | 41.0¢ | 39.5¢ | $1.158M | 2.895M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 29 | 205303 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 175090 | 17 |
View Market Depth
| Last trade - 15.43pm 11/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |